These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33351665)

  • 21. Identification of FOXM1-induced epigenetic markers for head and neck squamous cell carcinomas.
    Hwang S; Mahadevan S; Qadir F; Hutchison IL; Costea DE; Neppelberg E; Liavaag PG; Waseem A; Teh MT
    Cancer; 2013 Dec; 119(24):4249-58. PubMed ID: 24114764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognostic and predictive methylation biomarkers in HNSCC : Epigenomic diagnostics for head and neck squamous cell carcinoma (HNSCC)].
    Franzen A; Bootz F; Dietrich D
    HNO; 2020 Dec; 68(12):911-915. PubMed ID: 32613323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic regulation of VENTXP1 suppresses tumor proliferation via miR-205-5p/ANKRD2/NF-kB signaling in head and neck squamous cell carcinoma.
    Zhang LM; Su LX; Hu JZ; Wang M; Ju HY; Li X; Han YF; Xia WY; Guo W; Ren GX; Fan XD
    Cell Death Dis; 2020 Oct; 11(10):838. PubMed ID: 33037177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma.
    Cao W; Zhang ZY; Xu Q; Sun Q; Yan M; Zhang J; Zhang P; Han ZG; Chen WT
    Mol Cancer; 2010 Nov; 9():296. PubMed ID: 21092172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA methylation biomarkers for head and neck squamous cell carcinoma.
    Zhou C; Ye M; Ni S; Li Q; Ye D; Li J; Shen Z; Deng H
    Epigenetics; 2018; 13(4):398-409. PubMed ID: 29927694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
    Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
    PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unraveling the oral cancer lncRNAome: Identification of novel lncRNAs associated with malignant progression and HPV infection.
    Nohata N; Abba MC; Gutkind JS
    Oral Oncol; 2016 Aug; 59():58-66. PubMed ID: 27424183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Site-specific methylation patterns of the GAL and GALR1/2 genes in head and neck cancer: Potential utility as biomarkers for prognosis.
    Misawa K; Mochizuki D; Endo S; Mima M; Misawa Y; Imai A; Shinmura K; Kanazawa T; Carey TE; Mineta H
    Mol Carcinog; 2017 Mar; 56(3):1107-1116. PubMed ID: 27685843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue.
    Bhat S; Kabekkodu SP; Jayaprakash C; Radhakrishnan R; Ray S; Satyamoorthy K
    Virchows Arch; 2017 Apr; 470(4):445-454. PubMed ID: 28255813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma.
    Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; de Vos L; Franzen A; Schröck F; Bootz F; Kristiansen G; Schröck A; Dietrich D
    Oncotarget; 2016 Nov; 7(46):75827-75838. PubMed ID: 27716615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA methylation association with stage progression of head and neck squamous cell carcinoma.
    Ghafarpour V; Khansari M; Banaei-Moghaddam AM; Najafi A; Masoudi-Nejad A
    Comput Biol Med; 2021 Jul; 134():104473. PubMed ID: 34034219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sixteen Cellular Senescence-associated DNA Methylation Signature Predicts Overall Survival in Patients with Head and Neck Squamous Cell Carcinoma.
    Ye MH; Huang XY; Li CJ; Wu QJ; Liu F
    Chin J Dent Res; 2023 Dec; 26(4):235-248. PubMed ID: 38126369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune gene expression in head and neck squamous cell carcinoma patients.
    Lecerf C; Kamal M; Vacher S; Chemlali W; Schnitzler A; Morel C; Dubot C; Jeannot E; Meseure D; Klijanienko J; Mariani O; Borcoman E; Calugaru V; Badois N; Chilles A; Lesnik M; Krhili S; Choussy O; Hoffmann C; Piaggio E; Bieche I; Le Tourneau C
    Eur J Cancer; 2019 Nov; 121():210-223. PubMed ID: 31593831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA hypomethylation and upregulated
    Wang X; Shen J; Wang L; Deng L; Bo H; Luo Y; Cui Y
    Epigenomics; 2023 Mar; 15(5):293-306. PubMed ID: 37194576
    [No Abstract]   [Full Text] [Related]  

  • 36. The non-coding landscape of head and neck squamous cell carcinoma.
    Zou AE; Zheng H; Saad MA; Rahimy M; Ku J; Kuo SZ; Honda TK; Wang-Rodriguez J; Xuan Y; Korrapati A; Yu V; Singh P; Grandis JR; King CC; Lippman SM; Wang XQ; Hinton A; Ongkeko WM
    Oncotarget; 2016 Aug; 7(32):51211-51222. PubMed ID: 27323410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoter methylation of galanin receptors as epigenetic biomarkers for head and neck squamous cell carcinomas.
    Kanazawa T; Misawa K; Shinmura K; Misawa Y; Kusaka G; Maruta M; Sasaki T; Watanabe Y; Carey TE
    Expert Rev Mol Diagn; 2019 Feb; 19(2):137-148. PubMed ID: 30640567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of nucleolar protein 4 as a novel methylated tumor suppressor gene in head and neck cancer.
    Demokan S; Chuang AY; Pattani KM; Sidransky D; Koch W; Califano JA
    Oncol Rep; 2014 Feb; 31(2):1014-20. PubMed ID: 24337411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential expression and prognostic value of long non-coding RNA in HPV-negative head and neck squamous cell carcinoma.
    Haque SU; Niu L; Kuhnell D; Hendershot J; Biesiada J; Niu W; Hagan MC; Kelsey KT; Casper KA; Wise-Draper TM; Medvedovic M; Langevin SM
    Head Neck; 2018 Jul; 40(7):1555-1564. PubMed ID: 29575229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypomethylation of lncRNA H19 as a potential prognostic biomarker for oral squamous cell carcinoma.
    Lee EY; Song JM; Kim HJ; Park HR
    Arch Oral Biol; 2021 Sep; 129():105214. PubMed ID: 34333230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.